Exicure, inc. XCUR.US AI Analysis
BetaUS StockHealthcare
(No presentation for XCUR)
XCUR Value Score
3
24
15
Limited Growth
Analysis Conclusion
The stock has a lower value rating; if aiming for value investing, existing long-term positions might require gradual reduction.
XCUR Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of XCUR from 2018-05-22 till Now
- -37.58%
- Cumulative Return
- -6.47%
- Annual Return
- 59.08%
- Volatility
- -0.11
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from May, 2018 to June, 2025. (Total Trades: 2)
| XCUR | Sector | US Overall Market | |
|---|---|---|---|
| Wining Rate | 50% | 46% | 55% |
| Avg Return | 2% | 46.4% | 58.6% |
| Avg Profit | 59.3% | 146.2% | 131.3% |
| Avg Loss | -55.3% | -40.3% | -31.2% |
| Avg Risk-Reward Ratio | 107.2% | 363.1% | 421.4% |